SE8403905D0 - Liposomes and steroid esters - Google Patents
Liposomes and steroid estersInfo
- Publication number
- SE8403905D0 SE8403905D0 SE8403905A SE8403905A SE8403905D0 SE 8403905 D0 SE8403905 D0 SE 8403905D0 SE 8403905 A SE8403905 A SE 8403905A SE 8403905 A SE8403905 A SE 8403905A SE 8403905 D0 SE8403905 D0 SE 8403905D0
- Authority
- SE
- Sweden
- Prior art keywords
- sub
- liposomes
- sup
- compounds
- inflammatory conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Priority Applications (36)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8403905A SE8403905D0 (sv) | 1984-07-30 | 1984-07-30 | Liposomes and steroid esters |
DE8585850222T DE3581856D1 (de) | 1984-07-30 | 1985-06-28 | Steroidester enthaltende liposome. |
EP85850222A EP0170642B1 (en) | 1984-07-30 | 1985-06-28 | Liposomes containing steroid esters |
AT85850222T ATE60990T1 (de) | 1984-07-30 | 1985-06-28 | Steroidester enthaltende liposome. |
ZA855032A ZA855032B (en) | 1984-07-30 | 1985-07-03 | Liposomes containing steroid esters |
NO852672A NO168042C (no) | 1984-07-30 | 1985-07-03 | Analogifremgangsmaate for fremstilling av terapeutisk aktive steroidestere |
US06/752,257 US4693999A (en) | 1984-07-30 | 1985-07-03 | Liposomes containing steroid esters |
IS3026A IS1515B (is) | 1984-07-30 | 1985-07-09 | Lípósóm sem innihalda steroíð-estera |
PH32544A PH21644A (en) | 1984-07-30 | 1985-07-19 | Liposomes containing steroid esters |
DK336385A DK164509C (da) | 1984-07-30 | 1985-07-24 | Hidtil ukendte steroidforbindelser og fremgangsmaade til fremstilling af samme samt farmaceutisk praeparat til indgift i luftvejene |
AU45307/85A AU582173B2 (en) | 1984-07-30 | 1985-07-24 | Liposomes containing steroid esters |
NZ212861A NZ212861A (en) | 1984-07-30 | 1985-07-24 | Steroids and pharmaceutical compositions |
PL1985254681A PL145673B1 (en) | 1984-07-30 | 1985-07-25 | Method of obtaining novel stereoidic esters |
SU853929451A SU1493111A3 (ru) | 1984-07-30 | 1985-07-25 | Способ получени стероидных сложных эфиров |
CN 85105713 CN1017402B (zh) | 1984-07-30 | 1985-07-27 | 含有甾族化合物类固醇酯的脂质体的制备方法 |
HU852859A HU196827B (en) | 1984-07-30 | 1985-07-29 | Process for producing steroid esters and liposomes comprising the same |
KR1019850005440A KR930000045B1 (ko) | 1984-07-30 | 1985-07-29 | 스테로이드 에스테르류를 함유하는 리포솜의 제조 방법 |
CA000487649A CA1250830A (en) | 1984-07-30 | 1985-07-29 | Liposomes containing steroid esters |
FI852932A FI84914C (sv) | 1984-07-30 | 1985-07-29 | Förfarande för framställning av farmakologiskt aktiva steroidestrar |
DD85292279A DD248055A5 (de) | 1984-07-30 | 1985-07-29 | Verfahren zur herstellung eines pharmazeutischen praeparates |
ES545651A ES8704969A1 (es) | 1984-07-30 | 1985-07-29 | Un procedimiento para preparar esteres de esteroides. |
DD85279092A DD236535A5 (de) | 1984-07-30 | 1985-07-29 | Verfahren zur herstellung von steroidestern |
PT80884A PT80884B (pt) | 1984-07-30 | 1985-07-29 | Processo para a preparacao de novos esteres de esteroides e de composicoes farmaceuticas contendo liposomas que incluem este esteres |
CS855542A CS254342B2 (en) | 1984-07-30 | 1985-07-29 | Method of new steroid compounds production |
JP60166063A JPS6143110A (ja) | 1984-07-30 | 1985-07-29 | ステロイドエステルを含有するリポソーム |
IE189285A IE58074B1 (en) | 1984-07-30 | 1985-07-29 | Liposomes containing steroid esters |
EG448/85A EG17462A (en) | 1984-07-30 | 1985-07-29 | Liposomes and steroid esters |
SI8511238A SI8511238A8 (sl) | 1984-07-30 | 1985-07-30 | Postopek za pridobivanje farmacevtskega pripravka za primarno dajanje v respiratorni trakt |
YU123885A YU45735B (sh) | 1984-07-30 | 1985-07-30 | Postupak za dobijanje farmaceutskog preparata za primarno davanje u respiratorni trakt |
ES557143A ES8705895A1 (es) | 1984-07-30 | 1986-10-23 | Un procedimiento para preparar una composicion farmaceutica que comprende liposomas |
HR920587A HRP920587A2 (en) | 1984-07-30 | 1992-10-01 | Liposomes containing steroid esters a process for the preparation of stable camomile extract rich with active substances |
SG690/93A SG69093G (en) | 1984-07-30 | 1993-05-27 | Liposomes containing steroid esters |
LV930864A LV5527A3 (lv) | 1984-07-30 | 1993-06-30 | Panemiens steroidu esteru iegusanai |
HK782/93A HK78293A (en) | 1984-07-30 | 1993-08-05 | Liposomes containing steroid esters |
LTRP951A LT2257B (lt) | 1984-07-30 | 1993-09-06 | Steroidu esteriu gavimo budas |
CY173194A CY1731A (en) | 1984-07-30 | 1994-05-06 | Liposomes containing steroid esters |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8403905A SE8403905D0 (sv) | 1984-07-30 | 1984-07-30 | Liposomes and steroid esters |
Publications (1)
Publication Number | Publication Date |
---|---|
SE8403905D0 true SE8403905D0 (sv) | 1984-07-30 |
Family
ID=20356623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8403905A SE8403905D0 (sv) | 1984-07-30 | 1984-07-30 | Liposomes and steroid esters |
Country Status (29)
Country | Link |
---|---|
US (1) | US4693999A (sv) |
EP (1) | EP0170642B1 (sv) |
JP (1) | JPS6143110A (sv) |
KR (1) | KR930000045B1 (sv) |
AT (1) | ATE60990T1 (sv) |
AU (1) | AU582173B2 (sv) |
CA (1) | CA1250830A (sv) |
CS (1) | CS254342B2 (sv) |
CY (1) | CY1731A (sv) |
DD (2) | DD248055A5 (sv) |
DE (1) | DE3581856D1 (sv) |
DK (1) | DK164509C (sv) |
EG (1) | EG17462A (sv) |
ES (2) | ES8704969A1 (sv) |
FI (1) | FI84914C (sv) |
HK (1) | HK78293A (sv) |
HU (1) | HU196827B (sv) |
IE (1) | IE58074B1 (sv) |
IS (1) | IS1515B (sv) |
NO (1) | NO168042C (sv) |
NZ (1) | NZ212861A (sv) |
PH (1) | PH21644A (sv) |
PL (1) | PL145673B1 (sv) |
PT (1) | PT80884B (sv) |
SE (1) | SE8403905D0 (sv) |
SG (1) | SG69093G (sv) |
SU (1) | SU1493111A3 (sv) |
YU (1) | YU45735B (sv) |
ZA (1) | ZA855032B (sv) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880635B1 (en) * | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
SE8501693D0 (sv) * | 1985-04-04 | 1985-04-04 | Draco Ab | Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters |
SE8506015D0 (sv) * | 1985-12-19 | 1985-12-19 | Draco Ab | Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives |
SE8601457D0 (sv) * | 1986-04-01 | 1986-04-01 | Draco Ab | Compositions of liposomes and b?712-receptor active substances for inhalation |
US5811119A (en) * | 1987-05-19 | 1998-09-22 | Board Of Regents, The University Of Texas | Formulation and use of carotenoids in treatment of cancer |
US5690954A (en) * | 1987-05-22 | 1997-11-25 | Danbiosyst Uk Limited | Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material |
FR2619505B1 (fr) * | 1987-08-20 | 1990-08-31 | Dior Christian Parfums | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant |
GB8723846D0 (en) * | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
EP0397774A1 (en) * | 1988-02-04 | 1990-11-22 | Board Of Regents, The University Of Texas System | Formulation and use of retinoids in treatment of cancer and other diseases |
US4906476A (en) * | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
US5043165A (en) * | 1988-12-14 | 1991-08-27 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs |
WO1990006775A1 (en) * | 1988-12-14 | 1990-06-28 | Liposome Technology, Inc. | A novel nonphospholipid liposome composition for sustained release of drugs |
US5100662A (en) * | 1989-08-23 | 1992-03-31 | The Liposome Company, Inc. | Steroidal liposomes exhibiting enhanced stability |
US5469854A (en) * | 1989-12-22 | 1995-11-28 | Imarx Pharmaceutical Corp. | Methods of preparing gas-filled liposomes |
US6146657A (en) * | 1989-12-22 | 2000-11-14 | Imarx Pharmaceutical Corp. | Gas-filled lipid spheres for use in diagnostic and therapeutic applications |
US5776429A (en) * | 1989-12-22 | 1998-07-07 | Imarx Pharmaceutical Corp. | Method of preparing gas-filled microspheres using a lyophilized lipids |
US20020150539A1 (en) | 1989-12-22 | 2002-10-17 | Unger Evan C. | Ultrasound imaging and treatment |
US5922304A (en) | 1989-12-22 | 1999-07-13 | Imarx Pharmaceutical Corp. | Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents |
US5542935A (en) | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
US5585112A (en) * | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
US6001335A (en) * | 1989-12-22 | 1999-12-14 | Imarx Pharmaceutical Corp. | Contrasting agents for ultrasonic imaging and methods for preparing the same |
US6088613A (en) | 1989-12-22 | 2000-07-11 | Imarx Pharmaceutical Corp. | Method of magnetic resonance focused surgical and therapeutic ultrasound |
US6551576B1 (en) | 1989-12-22 | 2003-04-22 | Bristol-Myers Squibb Medical Imaging, Inc. | Container with multi-phase composition for use in diagnostic and therapeutic applications |
US5888995A (en) * | 1991-02-04 | 1999-03-30 | Astra Aktiebolag | Steroid esters |
SE9100341D0 (sv) * | 1991-02-04 | 1991-02-04 | Astra Ab | Novel steroids |
SE9100342D0 (sv) * | 1991-02-04 | 1991-02-04 | Astra Ab | Novel steroid esters |
US5874062A (en) * | 1991-04-05 | 1999-02-23 | Imarx Pharmaceutical Corp. | Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents |
US5205290A (en) | 1991-04-05 | 1993-04-27 | Unger Evan C | Low density microspheres and their use as contrast agents for computed tomography |
FR2675146A1 (fr) * | 1991-04-10 | 1992-10-16 | Roussel Uclaf | Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires. |
ES2137353T3 (es) * | 1993-01-08 | 1999-12-16 | Astra Ab | Nuevos derivados esteroides especificos del colon o del ileon. |
WO1994028876A1 (en) * | 1993-06-07 | 1994-12-22 | Advanced Therapies, Inc. | Liposome powders |
US7083572B2 (en) | 1993-11-30 | 2006-08-01 | Bristol-Myers Squibb Medical Imaging, Inc. | Therapeutic delivery systems |
US5635206A (en) * | 1994-01-20 | 1997-06-03 | Hoffmann-La Roche Inc. | Process for liposomes or proliposomes |
CH689139A5 (de) * | 1995-04-03 | 1998-10-30 | Cerbios Pharma Sa | Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung. |
US5997898A (en) * | 1995-06-06 | 1999-12-07 | Imarx Pharmaceutical Corp. | Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery |
US6033645A (en) * | 1996-06-19 | 2000-03-07 | Unger; Evan C. | Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
US6521211B1 (en) | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
US6139819A (en) * | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
US6231834B1 (en) | 1995-06-07 | 2001-05-15 | Imarx Pharmaceutical Corp. | Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same |
JP2001507207A (ja) | 1996-05-01 | 2001-06-05 | イマアーレクス・フアーマシユーチカル・コーポレーシヨン | 化合物を細胞に送達する方法 |
US5958378A (en) * | 1996-07-03 | 1999-09-28 | Research Development Foundation | High dose liposomal aerosol formulations containing cyclosporin A or budesonide |
TW497974B (en) * | 1996-07-03 | 2002-08-11 | Res Dev Foundation | High dose liposomal aerosol formulations |
US6414139B1 (en) | 1996-09-03 | 2002-07-02 | Imarx Therapeutics, Inc. | Silicon amphiphilic compounds and the use thereof |
US5846517A (en) | 1996-09-11 | 1998-12-08 | Imarx Pharmaceutical Corp. | Methods for diagnostic imaging using a renal contrast agent and a vasodilator |
DE69737915T2 (de) * | 1996-09-11 | 2008-03-13 | Bristol-Myers Squibb Medical Imaging, Inc. | Verfahren zur diagnostischen Bilderzeugung der Nierenregion unter Verwendung eines Kontrastmittels und eines Vasodilators |
GB2321455A (en) * | 1997-01-24 | 1998-07-29 | Norsk Hydro As | Lipophilic derivatives of biologically active compounds |
US6143276A (en) * | 1997-03-21 | 2000-11-07 | Imarx Pharmaceutical Corp. | Methods for delivering bioactive agents to regions of elevated temperatures |
US6537246B1 (en) | 1997-06-18 | 2003-03-25 | Imarx Therapeutics, Inc. | Oxygen delivery agents and uses for the same |
US6090800A (en) * | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
WO1998050041A1 (en) * | 1997-05-06 | 1998-11-12 | Imarx Pharmaceutical Corp. | Novel prodrugs comprising fluorinated amphiphiles |
US7452551B1 (en) | 2000-10-30 | 2008-11-18 | Imarx Therapeutics, Inc. | Targeted compositions for diagnostic and therapeutic use |
US6416740B1 (en) | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
US6548047B1 (en) | 1997-09-15 | 2003-04-15 | Bristol-Myers Squibb Medical Imaging, Inc. | Thermal preactivation of gaseous precursor filled compositions |
US6123923A (en) * | 1997-12-18 | 2000-09-26 | Imarx Pharmaceutical Corp. | Optoacoustic contrast agents and methods for their use |
US20010003580A1 (en) | 1998-01-14 | 2001-06-14 | Poh K. Hui | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
US6576224B1 (en) * | 1999-07-06 | 2003-06-10 | Sinuspharma, Inc. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
US20020061281A1 (en) * | 1999-07-06 | 2002-05-23 | Osbakken Robert S. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
CA2669753C (en) | 1999-09-30 | 2012-06-26 | Hollis-Eden Pharmaceuticals, Inc. | Therapeutic treatment of androgen receptor driven conditions |
CA2395132A1 (en) * | 2000-01-05 | 2001-07-12 | Imarx Therapeutics, Inc. | Pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
US20040009229A1 (en) * | 2000-01-05 | 2004-01-15 | Unger Evan Charles | Stabilized nanoparticle formulations of camptotheca derivatives |
DE10116197A1 (de) * | 2001-03-30 | 2002-10-17 | Bernina Biosystems Gmbh | Neue Methylprednisolonderivate mit therapeutischer Wirkung |
US20050009798A1 (en) | 2002-02-20 | 2005-01-13 | Sepracor Inc. | Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists |
AU2003217535A1 (en) | 2002-02-20 | 2003-09-09 | Sepracor Inc. | Carbonate and carbamate modified forms of glucocorticoids |
WO2003075889A1 (en) * | 2002-03-05 | 2003-09-18 | Transave, Inc. | An inhalation system for prevention and treatment of intracellular infections |
US20040235811A1 (en) * | 2002-10-08 | 2004-11-25 | Sepracor Inc. | Fatty acid modified forms of glucocorticoids |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
MXPA05004580A (es) * | 2002-10-29 | 2005-07-26 | Transave Inc | Liberacion sostenida de anti - infecciosos. |
AU2003257154A1 (en) * | 2003-08-05 | 2005-03-07 | Sepracor Inc. | AMINO ACID AND PEPTIDE-MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH ss2 ADRENERGIC AGONISTS |
HUE029994T2 (en) | 2005-12-08 | 2017-04-28 | Insmed Inc | Lipid-based preparations of antinfectants for the treatment of lung infections |
NO331891B1 (no) * | 2007-03-20 | 2012-04-30 | Clavis Pharma Asa | Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS |
WO2008137717A1 (en) | 2007-05-04 | 2008-11-13 | Transave, Inc. | Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
PT2852391T (pt) | 2012-05-21 | 2022-02-18 | Insmed Inc | Sistemas para tratamento de infeções pulmonares |
AU2013352259B2 (en) | 2012-11-29 | 2018-06-14 | Insmed Incorporated | Stabilized vancomycin formulations |
RS60827B1 (sr) | 2014-05-15 | 2020-10-30 | Insmed Inc | Postupci lečenja plućnih netuberkuloznih mikobakterijskih infekcija |
KR101961484B1 (ko) * | 2016-01-08 | 2019-03-22 | 최규선 | 생콩 탈피장치 |
US11571386B2 (en) | 2018-03-30 | 2023-02-07 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE378109B (sv) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
GB1575343A (en) * | 1977-05-10 | 1980-09-17 | Ici Ltd | Method for preparing liposome compositions containing biologically active compounds |
CH621479A5 (sv) * | 1977-08-05 | 1981-02-13 | Battelle Memorial Institute | |
FR2416008A1 (fr) * | 1978-02-02 | 1979-08-31 | Oreal | Lyophilisats de liposomes |
JPS609726B2 (ja) * | 1980-05-15 | 1985-03-12 | 株式会社 ミドリ十字 | ステロイド製剤 |
HU182775B (en) * | 1981-10-15 | 1984-03-28 | Richter Gedeon Vegyeszet | Process for preparing new 3-chloro-pregnane derivatives |
DE3228629A1 (de) * | 1982-07-31 | 1984-02-02 | Reifenrath, Rainer Richard Otto, Dr., 3104 Unterlüß | Pharmazeutisches erzeugnis zur behandlung der atemwege und verfahren zu seiner herstellung |
GB2135647A (en) * | 1983-02-15 | 1984-09-05 | Squibb & Sons Inc | Method of preparing liposomes and products produced thereby |
-
1984
- 1984-07-30 SE SE8403905A patent/SE8403905D0/sv unknown
-
1985
- 1985-06-28 AT AT85850222T patent/ATE60990T1/de not_active IP Right Cessation
- 1985-06-28 DE DE8585850222T patent/DE3581856D1/de not_active Expired - Lifetime
- 1985-06-28 EP EP85850222A patent/EP0170642B1/en not_active Expired - Lifetime
- 1985-07-03 NO NO852672A patent/NO168042C/no not_active IP Right Cessation
- 1985-07-03 ZA ZA855032A patent/ZA855032B/xx unknown
- 1985-07-03 US US06/752,257 patent/US4693999A/en not_active Expired - Lifetime
- 1985-07-09 IS IS3026A patent/IS1515B/is unknown
- 1985-07-19 PH PH32544A patent/PH21644A/en unknown
- 1985-07-24 AU AU45307/85A patent/AU582173B2/en not_active Expired
- 1985-07-24 DK DK336385A patent/DK164509C/da not_active IP Right Cessation
- 1985-07-24 NZ NZ212861A patent/NZ212861A/xx unknown
- 1985-07-25 PL PL1985254681A patent/PL145673B1/pl unknown
- 1985-07-25 SU SU853929451A patent/SU1493111A3/ru active
- 1985-07-29 FI FI852932A patent/FI84914C/sv not_active IP Right Cessation
- 1985-07-29 HU HU852859A patent/HU196827B/hu unknown
- 1985-07-29 KR KR1019850005440A patent/KR930000045B1/ko not_active IP Right Cessation
- 1985-07-29 ES ES545651A patent/ES8704969A1/es not_active Expired
- 1985-07-29 EG EG448/85A patent/EG17462A/xx active
- 1985-07-29 CA CA000487649A patent/CA1250830A/en not_active Expired
- 1985-07-29 DD DD85292279A patent/DD248055A5/de unknown
- 1985-07-29 IE IE189285A patent/IE58074B1/en not_active IP Right Cessation
- 1985-07-29 JP JP60166063A patent/JPS6143110A/ja active Granted
- 1985-07-29 PT PT80884A patent/PT80884B/pt unknown
- 1985-07-29 DD DD85279092A patent/DD236535A5/de unknown
- 1985-07-29 CS CS855542A patent/CS254342B2/cs unknown
- 1985-07-30 YU YU123885A patent/YU45735B/sh unknown
-
1986
- 1986-10-23 ES ES557143A patent/ES8705895A1/es not_active Expired
-
1993
- 1993-05-27 SG SG690/93A patent/SG69093G/en unknown
- 1993-08-05 HK HK782/93A patent/HK78293A/xx not_active IP Right Cessation
-
1994
- 1994-05-06 CY CY173194A patent/CY1731A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8403905D0 (sv) | Liposomes and steroid esters | |
MY102023A (en) | N-phenylnethylalkadienamide derivatives and compositions for use as analgeses | |
IE883048L (en) | Polyamine derivatives as antineoplastic agents | |
ES452550A1 (es) | Procedimiento para la preparacion de derivadas de acidos fe-noxialcohilcarboxilicos. | |
KR880013562A (ko) | 7-티아프로스타글란딘e₁ 또는 그의 유도체를 함유하는 당뇨병치료 조성물 | |
TH3073EX (th) | ไลโพโซมที่มีสเทอรอยด์เอสเทอร์ | |
ES2058315T3 (es) | Compuestos eficaces contra insuficiencia cerebral. | |
DE2963019D1 (en) | Novel 3-beta-amino-2-beta-hydroxy steroids of the androstane, oestrane and pregnane series, processes for their preparation and pharmaceutical compositions | |
TH3073A (th) | ไลโพโซมที่มีสเทอรอยด์เอสเทอร์ | |
NO167382C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-hydroxy-4-(substituerte alkenyl)cyklohexancarboxylsyrer. | |
KR890001527A (ko) | 에이즈 및 에이즈 관련 복합증상의 억제를 위한 아바콘, 아바롤 및 그 유도체의 용도 |